Cargando…
National trends in psychotropic medication prescribing before and during the COVID-19 pandemic()
The early months of the COVID-19 pandemic saw a decline in psychotropic medication use; however, little is known about how this trend evolved as the pandemic progressed and how it varied across different payers in the United States. Using a national multi-payer pharmacy claims database and adopting...
Autores principales: | Sanborn, Molly, Ali, Mir M., Creedon, Timothy B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier/North-Holland Biomedical Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165869/ https://www.ncbi.nlm.nih.gov/pubmed/37207543 http://dx.doi.org/10.1016/j.psychres.2023.115248 |
Ejemplares similares
-
National trends in buprenorphine prescribing before and during the COVID-19 pandemic
por: Ali, Mir M., et al.
Publicado: (2023) -
Psychotropic medication prescribing during the COVID-19 pandemic
por: Hirschtritt, Matthew E., et al.
Publicado: (2021) -
Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic
por: Luykx, Jurjen J., et al.
Publicado: (2020) -
Trends in Buprenorphine Prescribing for Opioid Use Disorder by Psychiatrists in the US From 2003 to 2021
por: Creedon, Timothy B., et al.
Publicado: (2023) -
National Prescribing Patterns of Psychotropic Medications in Older Adults in Oman
por: Al-Shehhi, Afaf, et al.
Publicado: (2023)